GlassScriptPhysician profile
Robert Phillip Dipilla
NPI 1841419561
$6,731.81
in general payments reported to CMS, 2019-2025
8 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.32 · 2020: $338 · 2021: $5,506 · 2022: $181 · 2023: $352 · 2024: $127 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Travel and Lodging: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.02 |
| Travel and Lodging | $127.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolase, INC. | $5,278.56 | 2019-2022 | |
| Align Technology, INC. | $767.83 | 2020-2025 | Itero Element 5d, Invisalign, Itero Element 5d Plus |
| A-Dec, INC. | $352.42 | 2021-2024 | |
| Dentsply Sirona INC | $143.33 | 2022-2025 | Cavitron |
| Zimmer Biomet Holdings, INC. | $97.37 | 2021 | |
| Philips North America LLC | $41.97 | 2021-2025 | Pic Ix Mobility |
| Ultradent Products INC | $36.49 | 2022 | |
| Solventum Corporation | $13.84 | 2025 | 3m Scotchbond, Clarity Aligners, 3m Filtek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dipilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.